Reaction

Torticollis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,071 reports · 58 co-occurring drugs

As of the last recalculation, Torticollis appears in 2,071 FAERS reports alongside 58 co-occurring drug terms. The strongest observed disproportionality signal is HALOPERIDOL LACTATE (PRR 32.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Haloperidol Lactate7832.933.0
Haloperidol7029.930.0
Levodopa3227.027.1
Ziprasidone3721.521.5
Aripiprazole Oral8421.221.3
Aripiprazole Orally Disintegrating8421.221.3
Ziprasidone Mesylate2820.020.0
Pramipexole2919.319.3
Risperidone17214.114.1
Aripiprazole15613.813.8
Butalbital, Acetaminophen, And Caffeine1413.313.3
Brexpiprazole2112.812.8
Valproate Sodium2512.312.3
Sevoflurane1012.112.2
Itraconazole1412.112.1
Olanzapine12112.012.0
Donepezil Hydrochloride4111.411.4
Propofol4011.211.2
Onabotulinumtoxina8211.111.1
Botulinum Toxin Type A1310.610.6
Paliperidone2310.010.0
Rivastigmine189.79.7
Zonisamide149.69.6
Lithium228.98.9
Lithium Bromatum228.98.9
Escitalopram Oxalate618.68.6
Torsemide288.68.6
Metoclopramide468.68.6
Indapamide158.58.5
Valproic Acid268.48.4
Metoclopramide Hydrochloride618.28.2
Olanzapine Pamoate328.08.0
Escitslopram457.97.9
Guanfacine67.77.7
Rotigotine117.77.7
Methylphenidate Hydrochloride437.47.4
Lurasidone Hydrochloride157.27.3
Amantadine117.27.2
Linezolid217.27.2
Quetiapine1287.17.1
Asenapine Maleate67.07.0
Fluoxetine456.96.9
Phenytoin146.86.8
Voriconazole Injection146.56.5
Sertraline736.46.4
Rasagiline Mesylate76.36.3
Voriconazole186.06.0
Memantine85.95.9
Memantine Hydrochloride85.95.9
Pyrazinamide55.45.4
Valbenazine135.25.2
Paliperidone Palmitate165.05.0
Clozapine604.94.9
Methylphenidate144.94.9
Amphetamine44.94.9
Carbidopa And Levodopa224.74.7
Rimegepant Sulfate54.04.0
Cinacalcet Hydrochloride61.31.3

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.